Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD80) costimulation

Journal of Immunotherapy

Volumn 19, Issue 1, 1996, Pages 1-8

  Wang, Yi Chong ^a   Zhu, Lihua ^a   McHugh, Rebecca ^a   Graham, Sam D ^a   Hillyer, Christopher D ^a   Dillehay, Dirk ^a   Sell, Kenneth W ^a   Selvaraj, Periasamy ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Costimulation; Cytotoxic activity; Renal carcinoma

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; OKT 8;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; KIDNEY CARCINOMA; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030004824     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199601000-00001     Document Type: Article

References (39)

1. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-80.
2. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
3. Chen L, Linsley PS, Hellstrom KE. Costimulation of T cells for tumor immunity. Immunol Today 1993;14:483-6.
4. Lanier L. Distribution and function of lymphocyte surface antigens: molecules costimulating T lymphocyte activation and function. Ann NY Acad Sci 1993;677:86-93.
5. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994;367:425-8.
6. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607-9.
7. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993;90:6586-90.
8. Tan P, Anasetti C, Hansen JA, et al. Induction of alloanti-gen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/ BB1. JExp Med 1993;177:165-73.
9. van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990;144:4579-86.
10. Damle NK, Klussman K, Aruffo A. Intercellular adhesion molecule-2, a second counter-receptor for CD1 la/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells. J Immunol 1992;148:665-71.
11. de Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-3 in immune responses. J Exp Med 1994;179:619-29.
12. van Seventer GA, Newman W, Yoji S, et al. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med 1991;174:901-13.
13. + T lymphocytes. Proc Natl Acad Sci USA 1991; 88: 6403-7.
14. + T lymphocytes. J Immunol 1992;148:1985-92.
15. Bierer BE, Peterson A, Gorga JC, Herrmann SH, Burakoff SJ. Synergistic T cell activation via the physiological ligands forCD2 and theT cell receptor. J Exp Med 1988;168:1145-56.
16. Dustin ML, Olive D, Springer TA. Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function associated antigen-3. J Exp Med 1989; 169:503-17.
17. Liu Y, Jones B, Aruffo A, Sullivan KM, Linsley PS, Janeway CA Jr. Heat stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med 1992;175:437-45.
18. Enk AH, Katz SI. Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans’ cells. J Immunol 1994;152:3264-70.
19. Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990;87:5031-5.
20. + T cells. J Exp Med 1991;173:759-62.
21. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-30.
22. Gimmi CD, Freeman GJ, Gribben JG, et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1991;88:6575-9.
23. Galvin F, Freeman GJ, Razi-Wolf Z, et al. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J Immunol 1992;149:3802-8.
24. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 1992;175:353-60.
25. Freeman GJ, Gribben JG, Boussiotis VA, et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;362:909-11.
26. Azuma M, Ito D, Yagita H, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9.
27. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand costimulatory forT cell activation. Science 1993;262:905-7.
28. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993;90:11059-63.
29. + T cells by B7-transfected melanoma cells. Science 1993;259:368-70.
30. Chen L, Ashe S, Brady WA, et al. Costimulation of antitumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992;71:1093-1102.
31. Baskar S, Ostrand Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 1993;90:5687-90.
32. Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellstrom I, Hellstrom KE. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med 1994;179:523-32.
33. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol 1989;143:2714-22.
34. Azuma M, Cayabyab M, Phillips JH, Lanier LL. Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol 1993;150:2091-101.
35. Ramarathinam L, Castle M, Wu Y, Liu Y. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in induction recruitment and effector function of anti-tumor T cells. J Exp Med 1994;179:1205-14.
36. Chen PW, Shreedhar VK, Ananthaswamy HN. Rejection of murine melanoma cells transfected with the intercellular adhesion molecule-1 gene. Int J Oncol 1995;6:675-680.
37. Damle NK, Klussman K, Leytze G, et al. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. Cell Immunol 1993;148:144-56.
38. Damle NK, Klussman K, Linsley PS, Aruffo A, Ledbetter JA. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J Immunol 1992;149:2541-8.
39. + T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles. J Immunol 1994;153:2479-87.